Medicare utilization — JASON R MICHAELS (MD)
Calendar year 2023 · data refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Allowed | Payment |
|---|---|---|---|---|---|
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 6,550 | 42 | $0 | $377 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 805 | 70 | $0 | $77 |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 391 | 229 | $0 | $35,105 |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | 144 | 144 | $0 | $17,796 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 109 | 83 | $0 | $1,018 |
Service volume and Medicare payment amounts do not indicate quality of care, patient outcomes, or fraud. Data reflects Medicare fee-for-service only.
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·